Cargando…
Incidence of adverse cardiovascular events associated with immune checkpoint inhibitors and risk factors for left ventricular dysfunction: A single-center prospective clinical study
BACKGROUND: The incidence of immune checkpoint inhibitors (ICI)-related adverse cardiovascular events (ACEs) may be underestimated, and there are few reports on the incidence and risk factors of ICI-induced left ventricular dysfunction (LVD). OBJECTIVES: This study aimed to investigate the incidence...
Autores principales: | Zhang, Chuan, Chen, Zhulu, Qin, Shu, Zhu, Yuxi, Shu, Linjie, Zuo, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899928/ https://www.ncbi.nlm.nih.gov/pubmed/36755798 http://dx.doi.org/10.3389/fcvm.2023.1052699 |
Ejemplares similares
-
Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction
por: Yoshioka, Goro, et al.
Publicado: (2022) -
Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022
por: Wu, Si, et al.
Publicado: (2022) -
Prognostic impact of implantable cardioverter defibrillators and associated adverse events in patients with continuous flow left ventricular assist devices
por: Pausch, Jonas, et al.
Publicado: (2023) -
Influence of Right Ventricular Dysfunction on Outcomes of Left Ventricular Non-compaction Cardiomyopathy
por: Wang, Wuwan, et al.
Publicado: (2022) -
Right ventricular dysfunction in a hypertensive population stratified by patterns of left ventricular geometry
por: Karaye, Kamilu M, et al.
Publicado: (2012)